GT Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	5	11	29	93	33	5	33	-	-	-	-
Market Cap Growth	-	-63.37%	-69.08%	181.07%	507.58%	-83.27%	-	-	-	-	-
Enterprise Value	-9	-3	12	61	54	19	43	-1	12	9	2
PE Ratio	-1.39	-1.39	-1.38	-1.61	-1.17	-0.14	-0.13	-	-	-	-
PB Ratio	0.67	1.41	2.46	4.26	-1.13	-0.28	2.83	-	-	-	-
P/FCF Ratio	-1.19	-1.19	-1.90	-5.98	-4.57	-1.58	-3.05	-	-	-	-
P/OCF Ratio	-1.19	-1.19	-1.90	-5.98	-4.57	-1.49	-3.06	-	-	-	-
EV/Sales Ratio	-	-	-	-	-	-	-	-	-	333.67	29.72
EV/EBITDA Ratio	0.45	0.45	-0.60	-1.07	-2.14	-0.51	-0.17	0.00	0.72	-2.05	-
EV/EBIT Ratio	0.45	0.45	-0.60	-1.07	-2.14	-0.51	-0.17	0.00	0.72	-2.05	-0.10
EV/FCF Ratio	0.38	0.38	-0.82	-3.93	-7.47	-5.43	-4.05	0.10	-6.06	-1.93	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	-0.89	-0.70	0.94	0.00	-0.63	-0.18	-0.09
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	0.00	-1.04	-0.37	-0.04	0.00	0.72	-2.06	-
Debt / FCF Ratio	-0.01	-0.01	-0.01	0.00	-3.63	-3.86	-1.01	-0.01	-6.07	-1.94	-
Quick Ratio	2.11	2.11	3.34	3.12	0.15	0.00	0.01	0.22	0.00	0.00	0.03
Current Ratio	2.12	2.12	3.35	3.14	0.16	0.01	0.01	0.22	0.00	0.00	0.03
Asset Turnover	0	0	0	0	0	0	0	0	0	0.06	-
Interest Coverage	-34.67	-34.67	-2609.50	-79.80	-8.42	-17.16	-27.43	-15.76	2.49	-0.26	-3.56
Return on Equity (ROE)	-71.80%	-71.80%	-137.10%	-202.50%	105.70%	862.30%	-198.00%	-123.70%	-54.60%	53.70%	-
Return on Assets (ROA)	-44.40%	-44.40%	-93.40%	-171.70%	-1426.20%	-296.60%	-183.70%	-113.30%	6690.40%	-4550.10%	-
Return on Capital (ROIC)	-180.20%	-180.20%	-178.51%	-262.13%	218.26%	277.64%	-1119.23%	-53.82%	133.29%	21.59%	8.96%
Earnings Yield	-150.76%	-71.93%	-72.42%	-62.19%	-85.27%	-707.56%	-793.88%	-	-	-	-
FCF Yield	-175.66%	-83.81%	-52.77%	-16.73%	-21.88%	-63.33%	-32.81%	-	-	-	-
Buyback Yield / Dilution	-26.87%	-26.87%	-13.19%	-542.06%	-29.59%	-14.50%	-199.60%	-20450.00%	96.59%	-2.87%	-
Total Shareholder Return	-26.87%	-26.87%	-13.19%	-542.06%	-29.59%	-14.50%	-199.60%	-20450.00%	96.59%	-2.87%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).